Evidence map›Paper›PMID 33178982›Full record

ArticleBJR open2020

Diffusion of innovation in radiation oncology in the United States.

Patricia Sansourekidou, Vasileios Margaritis, Wen-Hung Kuo

Abstract read
In one paragraph

Article in BJR open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Patricia SansourekidouDepartment of Radiation Oncology, Montefiore Health System - White Plains Hospital Center for Cancer Care, White Plains, NY, 10601, United States.ORCID 0000-0001-9107-175X
Vasileios MargaritisWalden University, Minneapolis, MN, United States.
Wen-Hung KuoWalden University, Minneapolis, MN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop an instrument for quantifying innovation and assess the diffusion of innovation in radiation oncology (RO) in the United States.

methodsPrimary data were collected for using total population convenience sampling. Innovation Score and Innovation Utilization Score were determined using 20 indicators. 240 medical physicists (MPs) practicing in RO in the United States completed a custom Internet-based survey.

resultsCenters with no academic affiliation are trailing behind in innovation in total (MD = 1.65, 95% C I[0.38,2.917],

conclusionsThere is a wide range of innovation across RO centers in the United States. RO centers in the United States are not practicing as innovative as reasonably achievable. ADVANCES IN KNOWLEDGE: This work quantified how innovative RO in the United States is and results provide guidance on how to improve it in the future.

Identifiers

PMID33178982
PMCPMC7583171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.